Clinical Trial Update: Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for treatment of moderate to severe lateral canthal lines and glabellar lines, alone or in combination, completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines
• Lateral Canthal Lines

Snippet

Sponsor: Galderma R&D | Conditions: Glabellar Frown Lines (GL), Lateral Canthal Lines (LCL) | Phase 3 | Status: COMPLETED | Results posted: 2023-09-06